Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors

Breast Cancer Research and Treatment

Volumn 133, Issue 2, 2012, Pages 413-416

  Henry, N Lynn ^a   Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CATECHOL METHYLTRANSFERASE; DULOXETINE; METHIONINE; MILNACIPRAN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; VALINE;

ACUPUNCTURE; ALLODYNIA; AROMATASE INHIBITOR MUSCULOSKELETAL SYNDROME; BREAST CANCER; BREAST SURGERY; CANCER FATIGUE; CANCER PAIN; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC PAIN; CLINICAL DECISION MAKING; COGNITIVE THERAPY; COMT GENE; FIBROMYALGIA; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART FAILURE; HUMAN; HYPERALGESIA; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL DISEASE; NOCICEPTION; NOTE; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; TREATMENT OUTCOME;

BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; FATIGUE; FEMALE; GENOTYPE; HUMANS; PAIN; SURVIVORS;

EID: 84863723234     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1804-8     Document Type: Note

References (29)

1. American Cancer Society: Breast Cancer Facts & Figures 2009-2010. http://www.cancer.org/research/cancerfactsfigures/breastcancer factsfigures/breast-cancer-facts-figures-2009-2010. Accessed 25 Aug 2011
2. Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26:768-777
3. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, Clauw DJ (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50:613-623
4. Gracely RH, Petzke F, Wolf JM, Clauw DJ (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46:1333-1343
5. Clauw D (2003) The health consequences of the first gulf war. Br Med J 327:1357-1358
6. Clauw DJ, Engel CC Jr, Aronowitz R, Jones E, Kipen HM, Kroenke K, Ratzan S, Sharpe M, Wessely S (2003) Unexplained symptoms after terrorism and war: an expert consensus statement. J Occup Environ Med 45:1040-1048
7. Hassett AL, Clauw DJ (2010) The role of stress in rheumatic diseases. Arthritis Res Ther 12:123
8. Mogil JS, Yu L, Basbaum AI (2000) Pain genes?: natural variation and transgenic mutants. Annu Rev Neurosci 23:777-811
9. Diatchenko L, Slade GD, Nackley AG et al (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135-143
10. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT Val158Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243
11. Costigan M, Belfer I, Griffin RS et al (2010) Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 133:2519-2527
12. Tegeder I, Costigan M, Griffin RS et al (2006) GTP cyclohy-drolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12:1269-1277
13. Valdes AM, De Wilde G, Doherty SA et al (2011) The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis 70:1556-1561
14. Galvan A, Fladvad T, Skorpen F, Gao X, Klepstad P, Kaasa S, Dragani TA (2011) Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry. Pharmacogenomics J. doi:10.1038/tpj.2011.27
15. Droney J, Riley J, Ross JR (2011) Evolving knowledge of opioid genetics in cancer pain. Clin Oncol 23:418-428
16. Williams DA, Clauw DJ (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10:777-791
17. Fernandez-de-Las-Penas C, Fernandez-Lao C, Cantarero-Vi-llanueva I, Ambite-Quesada S, Rivas-Martinez I, del Moral-Avila R, Arroyo-Morales M (2011) Catechol-o-methyltransferase genotype (Val158Mmet) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Res Treat (in press)
18. van Meurs JB, Uitterlinden AG, Stolk L, Kerkhof HJ, Hofman A, Pols HA, Bierma-Zeinstra SM (2009) A functional polymorphism in the catechol-o- methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum 60:628-629
19. McLean SA, Diatchenko L, Lee YM et al (2011) Catechol o-methyltransferase haplotype predicts immediate musculoskel-etal neck pain and psychological symptoms after motor vehicle collision. J Pain 12:101-107
20. Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot M (2008) Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain 138:22-28
21. Dodd MJ, Cho MH, Cooper BA, Miaskowski C (2010) The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 14:101-110
22. Aktas A, Walsh D, Rybicki L (2010) Symptom clusters: myth or reality? Palliat Med 24:373-385
23. Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF (2005) A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119:5-15
24. Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H (2009) Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 146:253-260
25. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH (2009) The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 36:398-409
26. Thieme K, Gracely RH (2009) Are psychological treatments effective for fibromyalgia pain? Curr Rheumatol Rep 11:443-450
27. Henry NL, Giles JT, Stearns V (2008) Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology (Williston Park) 22:1401-1408
28. Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, Yann Tsai W, Hershman DL (2010) Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 28:1154-1160
29. Henry NL, Banerjee M, Wicha M, Van Poznak C, Smerage JB, Schott AF, Griggs JJ, Hayes DF (2011) Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. Cancer. doi:10.1002/cncr.26230